Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Donor Chimerism at Day +90 Predicts Better Survival Outcomes Among Allogeneic Hematopoietic Cell Transplantation Recipients Receiving Myeloablative Conditioning
SJ
Sara Jubas
University of North Carolina at Chapel Hill
KC
Kieran D. Collins
HL
Hsuan-Hui Liu
Ver todo
Puntos clave
Improved survival outcomes associate strongly with high levels of donor chimerism.
The analysis indicated that donor chimerism was a predictor of survival at Day +90 post-transplant.
Assessment of donor chimerism occurs at the 90-day mark after myeloablative conditioning.
Findings suggest donor chimerism may serve as an important biomarker for transplantation success.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Donor Chimerism at Day +90 Predicts Better Survival Outcomes Among Allogeneic Hematopoietic Cell Transplantation Recipients Receiving Myeloablative Conditioning | Synapse
Cite This Study
Copy
Jubas et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760d5c6e9836116a2df62
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.579